Programme
HTLV CONFERENCE 2026 – Tentative plan & schedule
WORKSHOPS: June 3rd (Wednesday)
| 9:00 -10:00am | Registration (Continued all day) | |
|---|---|---|
| 1:00 – 3:00pm |
Workshop 1Public Health, Transmission, and Community Engagement Ensuring blood safety, and interrupting HTLV transmission HTLV-1 Pre-Exposure Prophylaxis Working Group Fabiola Martin, Australia Public heath impact of HTLV in vulnerable populations and geographic areas in Peru Eduardo Gotuzzo, Peru HTLV transmission in Europe Andrea Thoma-Kress, Germany Status of HTLV-1 in Aboriginals communities Lloyd Einsiedel, Australia HTLV challenges and opportunities in the international public health TBC |
Workshop 2Molecular Virology and Immunopathogenesis Molecular Virology of HTLV Mechanisms of latent HTLV-1 infection, clonal evolution and genetic landscape of ATLL Yorifumi Satou HTLV-1-induced immune dysfunction Helene Dutartre, France HTLV-1 particle assembly and transmission Louis Mansky, USA HTLV-1 immunopathogenesis Sharron Manuel, USAGenetic landscape and clonal evolution of ATLL Aileen Rowan (UK) |
| 3:00 – 3:30pm | Coffee break | |
| 3:30 – 5:30pm |
Workshop 3HTLV epidemiology, phylogenetics, and diagnostics Standardizing molecular diagnosis of HTLV infections Genetic diversity of HTLV-1 and its molecular epidemiology Philippe Afonso , France Diagnosis of HTLV infections in early life Carolina Rosadas Prognostic – CNS Biomarkers of HTLV-associated neuroinflammation Yoshi Yamano Molecular epidemiology of HTLVs in the Americas TBC Antonio Vallinoto, Brazil IRVA Africa meeting, safety of blood transfusions in Africa and the need to inform public policy Jean-Claude Twizere, Belgium |
Workshop 4Preclinical models, clinical guidelines, and trials HTLV animal models (ATLL & HAM/TSP) US National Cancer Research Network (NCCN) guidelines Steven Horwitz, USA Targeting Epigenetic and Other Pathways in ATLL Toshiki Watanabe, Japan Evidence-based treatment recommendations for ATLL Lucy Cook, London Advances in Stem Cell Transplant for ATLL Ali Bazarbachi, Lebnon Current & emerging therapeutic strategies for ATLL in USA Georgios Pongas, University of Miami, USA |
| 5:30 -7:00 pm | Welcome Reception | |